Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
208 participants
INTERVENTIONAL
2025-04-01
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study, led by White Plains Hospital (WPH) Cares, will follow 208 patients for 90 days after their discharge. Half of the participants will receive standard care, while the other half will receive a Dexcom G7 CGM device along with support from trained nurses who will monitor their glucose readings daily. The goal is to determine whether this approach helps lower Hemoglobin A1c (HbA1c) levels, reduces hospital readmissions, and improves overall health outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations
NCT06939413
Telemedicine Monitoring of Nocturnal Incidents
NCT04328896
A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring
NCT05911256
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
NCT06852950
Dexcom Continuous Glucose Monitoring in Long-term Care
NCT04818242
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Arm -standard of care
No interventions assigned to this group
Intervention Arm
Continuous glucose monitoring, remote patient monitoring for 90 days
Continues glucose monitoring with remote glucose monitoring for 90 days
CGM + RPM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continues glucose monitoring with remote glucose monitoring for 90 days
CGM + RPM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
White Plains Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Andersen JA, Scoggins D, Michaud T, Wan N, Wen M, Su D. Racial Disparities in Diabetes Management Outcomes: Evidence from a Remote Patient Monitoring Program for Type 2 Diabetic Patients. Telemed J E Health. 2021 Jan;27(1):55-61. doi: 10.1089/tmj.2019.0280. Epub 2020 Apr 17.
Elsener M, Santana Felipes RC, Sege J, Harmon P, Jafri FN. Telehealth-based transitional care management programme to improve access to care. BMJ Open Qual. 2023 Nov;12(4):e002495. doi: 10.1136/bmjoq-2023-002495.
Greenwood DA, Young HM, Quinn CC. Telehealth Remote Monitoring Systematic Review: Structured Self-monitoring of Blood Glucose and Impact on A1C. J Diabetes Sci Technol. 2014 Mar;8(2):378-389. doi: 10.1177/1932296813519311. Epub 2014 Feb 21.
Salehi S, Olyaeemanesh A, Mobinizadeh M, Nasli-Esfahani E, Riazi H. Assessment of remote patient monitoring (RPM) systems for patients with type 2 diabetes: a systematic review and meta-analysis. J Diabetes Metab Disord. 2020 Jan 10;19(1):115-127. doi: 10.1007/s40200-019-00482-3. eCollection 2020 Jun.
Pal K, Eastwood SV, Michie S, Farmer A, Barnard ML, Peacock R, Wood B, Edwards P, Murray E. Computer-based interventions to improve self-management in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2014 Jun;37(6):1759-66. doi: 10.2337/dc13-1386.
Boye KS, Thieu VT, Lage MJ, Miller H, Paczkowski R. The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study. Adv Ther. 2022 May;39(5):2208-2221. doi: 10.1007/s12325-022-02106-4. Epub 2022 Mar 22.
Steinhubl SR, Muse ED, Topol EJ. The emerging field of mobile health. Sci Transl Med. 2015 Apr 15;7(283):283rv3. doi: 10.1126/scitranslmed.aaa3487.
Rodriguez-Gutierrez R, Herrin J, Lipska KJ, Montori VM, Shah ND, McCoy RG. Racial and Ethnic Differences in 30-Day Hospital Readmissions Among US Adults With Diabetes. JAMA Netw Open. 2019 Oct 2;2(10):e1913249. doi: 10.1001/jamanetworkopen.2019.13249.
Soh JGS, Wong WP, Mukhopadhyay A, Quek SC, Tai BC. Predictors of 30-day unplanned hospital readmission among adult patients with diabetes mellitus: a systematic review with meta-analysis. BMJ Open Diabetes Res Care. 2020 Aug;8(1):e001227. doi: 10.1136/bmjdrc-2020-001227.
Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta, GA, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, 2020, p. 12-15
U.S. Census Bureau. (2022). How has Westchester County's Racial and Ethnic Populations Changed. USA Facts. https://usafacts.org/data/topics/people-society/population-and-demographics/our-changing-population/state/new-york/county/westchester-county/. Accessed 12/9/2023.
Westchester Community Foundation (2018) Health: Diabetes Mortality, by Race/Ethnicity. Westchester Index; An Initiative of Westchester County Foundation. https://westchesterindex.org/health/diabetes-mortality-by-race-ethnicity
Smithwick, K. (n.d.). Diabetes Mortality, by race/ethnicity. Westchester Index. Retrieved November 3, 2022, from https://westchesterindex.org/health/diabetes-mortality-by-race-ethnicity.
NY DOH, (2018). Percentage of Adults with Diagnosed Diabetes, by county, New York State, BRFSS 2018. New York Health. https://www.health.ny.gov/statistics/prevention/injury_prevention/information_for_action/docs/2021-01_ifa_report.pdf
CDC. (n.d.). Diabetes State Burden Toolkit. Center for Disease Control and Prevention. https://nccd.cdc.gov/Toolkit/DiabetesBurden/TotalCost. Accessed 12/8/2023.
American Diabetes Association. (2021). The Burden of Diabetes in New York. American Diabetes Association. https://www2.diabetes.org/sites/default/files/2021-11/ADV_2021_State_Fact_sheets_New%20York_rev.pdf
CDC. (n.d.). Diabetes Data and Statistics. Center for Disease Control and M/edicine. Diabetes Data and Statistics. CDC. https://www.cdc.gov/diabetes/data/statistics-report/index.html. Accessed 12/7/2023
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WPH IRB: 2025-16585
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.